7Baggers

Inovio Pharmaceuticals Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -0.130.310.751.191.632.072.512.95Billion

Inovio Pharmaceuticals Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2004-06-30 2004-03-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 2002-06-30 2002-03-31 2001-12-31 2001-09-30 2001-06-30 2001-03-31 2000-12-31 2000-09-30 2000-06-30 2000-03-31 1999-12-31 1999-09-30 1999-06-30 1999-03-31 1998-12-31 
  revenue102,651 388,446 225,971 114,943 124,666 9,154,133 784,395 199,074 839,115 291,698 272,824 371,120 5,580,581 236,178 267,187 1,327,274 279,488 866,863 135,673 2,829,905 2,502,624 2,000,868 24,448,761 1,529,644 8,787,234 2,644,543 20,412,124 10,376,185 8,513,952 12,540,463 6,203,791 8,110,155 5,935,562 24,183,234 5,286,678 5,166,637 2,457,108 1,840,353 3,801,662 2,357,643 1,739,666 9,486,845 785,610 1,455,225 1,134,753 854,696 436,082 1,693,121 1,632,668 2,637,561 2,419,763 3,105,265 2,359,914 1,276,543 1,134,859 1,373,389 2,612,611 3,646,461 2,491,589 369,450 326,847 454,737 663,034 653,014 3,321,739 486,511 495,577 503,902 1,531,666 575,829 662,690 697,993 829,237 724,480 2,951,616 961,921 542,738 455,157 99,819 69,385 38,077 22,311 9,004 11,137 76,193 67,887 40,971 791,533 1,001,080 1,301,826 837,722 1,312,311 1,190,906 1,354,063 1,252,176 1,477,339 1,300,000 1,500,000 900,000 5,200,000 900,000 
  cost of revenue175,227 1,032,775 1,143,410 30,176,511 1,348,494 1,361,743 1,410,050 56,250 56,250 225,000 56,250 56,250 56,250 206,250 56,250 56,250 316,535 316,535 778,521 592,075 367,116 187,406 317,348 445,548 319,319 557,541 400,000 300,000 200,000 300,000 200,000 
  gross profit-72,576 -644,329 -917,439 -30,061,568 -1,223,828 7,792,390 -625,655 199,074 839,115 291,698 272,824 371,120 5,580,581 236,178 267,187 1,327,274 279,488 866,863 135,673 2,829,905 2,502,624 2,000,868 24,448,761 1,529,644 8,787,234 2,644,543 20,412,124 10,376,185 8,513,952 12,540,463 6,203,791 8,110,155 5,935,562 24,183,234 5,286,678 5,166,637 2,457,108 1,840,353 3,801,662 2,357,643 1,739,666 9,486,845 785,610 1,455,225 1,134,753 854,696 436,082 1,693,121 1,632,668 2,637,561 2,419,763 3,105,265 2,359,914 1,276,543 1,134,859 1,373,389 2,612,611 3,646,461 2,491,589 369,450 326,847 454,737 663,034 653,014 3,321,739 486,511 439,327 447,652 1,306,666 519,579 606,440 641,743 622,987 668,230 2,895,366 961,921 542,738 455,157 99,819 69,385 38,077 22,311 9,004 11,137 -240,342 67,887 40,971 474,998 222,559 709,751 470,606 1,124,905 873,558 908,515 932,857 919,798 900,000 1,200,000 700,000 4,900,000 700,000 
  operating expenses                                                                                                     
  research and development17,253,050 15,503,032 23,743,970 30,176,511 42,119,877 33,087,130 56,464,885 55,978,611 92,298,819 47,088,669 70,808,418 39,044,418 26,302,561 26,455,112 22,376,575 19,111,188 22,003,955 19,137,209 22,486,266 24,389,888 26,365,647 21,851,858 22,462,620 24,577,751 24,641,124 25,510,239 23,878,751 24,542,504 23,911,731 26,980,343 19,630,801 18,189,160 15,601,891 16,075,201 16,688,511 9,426,320 9,244,473 7,017,805 9,607,281 8,225,480 6,404,005 5,438,405 4,411,082 5,115,112 4,442,841 4,972,319 4,527,086 4,042,579 4,158,400 6,987,824 4,463,978 4,421,799 4,491,715 2,951,067 3,083,229 2,730,595 3,851,400 3,412,130 1,181,194 963,733 1,199,455 1,274,387 1,679,264 1,597,388 1,866,322 2,335,378 2,907,836 2,516,411 2,701,534 2,185,931 1,981,895 1,640,425 2,181,725 2,413,044 3,519,623 3,340,381 2,586,006 2,387,291 986,443 588,860 598,508 643,433 429,235 475,734 614,704 593,705 633,735 662,512 3,003,264 803,607 873,060 1,786,308 1,824,034 1,431,205 1,394,830 1,977,220 1,400,000 1,700,000 2,000,000 2,000,000 2,300,000 
  sales, general and administrative                                                                                                     
  total operating expenses27,321,164 35,941,458 37,267,068 44,067,121 56,070,821 44,911,177 104,921,721 71,932,069 106,347,454 60,244,852 83,474,759 52,925,612 34,920,019 36,565,618 33,448,085 26,559,542 30,700,541 24,818,650 28,336,367 31,364,917 32,001,788 28,643,551 29,651,930 34,275,766 32,675,023 31,830,014 30,047,857 32,310,093 30,877,248 32,735,946 25,430,331 23,560,773 20,461,977 20,452,817 21,406,771 13,534,248 13,468,902 10,171,519 13,954,608 12,357,698 10,743,544 8,721,201 7,457,668 8,089,265 7,361,841 7,646,681 7,223,995 6,530,667 7,412,390 9,311,012 7,556,364 7,741,031 7,640,231 5,833,061 6,110,822 5,780,753 6,423,192 7,242,833 5,481,966 3,929,875 3,788,444 3,203,315 4,765,444 3,998,893 5,133,089 5,513,101 5,252,387 4,807,572 5,325,422 4,112,559 3,865,416 3,510,975 3,896,963 3,757,784 5,136,858 4,850,618 4,429,614 3,997,119 2,565,008 1,686,056 1,846,045 1,719,753 1,408,795 1,756,427 1,518,342 1,540,063 1,564,167 1,940,770 3,961,893 2,418,034 3,209,443 3,073,806 3,141,127 2,980,730 2,973,439 3,454,408 2,700,000 3,200,000 3,700,000 3,800,000 3,900,000 
  operating income-27,393,740 -35,553,012 -37,041,097 -43,952,178 -55,946,155 -35,757,044 -104,137,326 -71,732,995 -105,508,339 -59,953,154 -83,201,935 -52,554,492 -29,339,438 -36,329,440 -33,180,898 -25,232,268 -30,421,053 -23,951,787 -28,200,694 -28,535,012 -29,499,164 -26,642,683 -5,203,169 -32,746,122 -22,887,789 -29,185,471 -9,635,733 -21,933,908 -22,363,296 -20,195,483 -18,226,540 -15,450,618 -14,526,415 3,730,417 -15,120,093 -8,367,611 -11,011,794 -8,331,166 -10,152,946 -10,000,055 -8,003,878 765,644 -5,672,058 -6,634,040 -6,227,088 -6,291,985 -6,787,913 -4,186,546 -5,779,722 -6,336,451 -5,136,601 -4,635,766 -5,280,317 -4,556,518 -4,975,963 -4,407,364 -3,810,581 -3,596,372 -2,990,377 -3,560,425 -3,461,597 -2,748,578 -4,102,410 -3,345,879 -1,811,350 -5,026,590 -4,756,810 -4,303,670 -3,793,756 -3,536,730 -3,202,726 -2,812,982 -3,067,726 -3,033,304 -2,185,242 -7,220,697 -3,886,876 -3,541,962 -2,465,189 -1,616,671 -1,807,968 -1,697,442 -1,399,791 -1,745,290 -1,442,149 -1,472,176 -1,523,196 -1,465,772 819,929 -1,708,283 -2,738,837 -3,248,528 -2,267,569 -2,072,215 -2,040,582 -2,534,610 -1,800,000 -2,000,000 -3,000,000 1,100,000 -3,200,000 
  net income-25,003,638 -33,929,864 -35,534,533 2,948,723,683 -51,668,285 -39,617,180 -112,464,412 -83,914,360 -106,947,580 -60,169,041 -82,139,958 -54,402,131 -24,338,380 19,171,336 -128,703,059 -32,541,054 -37,662,038 -23,090,693 -29,387,226 -29,219,262 -32,962,205 -25,015,672 -6,639,125 -32,350,828 -21,506,179 -34,134,570 -9,479,116 -23,085,907 -26,233,470 -20,759,338 -18,704,711 -8,042,820 -17,952,045 5,594,468 -6,248,250 -10,581,779 -7,411,404 -7,177,575 -10,711,274 -10,821,460 -15,454,330 -30,877,410 -10,852,588 -8,844,120 -658,751 -6,622,076 -4,133,179 -8,254,949 -5,476,241 -4,541,932 -2,822,159 -2,412,613 -6,293,524 -1,410,148 -7,616,438 -2,293,686 -7,345,868 -2,948,186 -10,652,936 -3,464,495 -3,575,733 -2,344,408 -4,023,772 -3,021,709 1,956,912 -4,620,991 -4,469,548 -4,070,816 -3,387,613 -3,408,881 -3,048,770 -2,633,860 -3,035,249 -2,990,799 -2,131,005 -7,139,799 -3,794,418 -3,431,750 -2,165,133 -1,581,632 -1,765,403 -1,680,313 -1,397,238 178,048 -1,574,799 -1,390,905 -1,537,307 -1,461,816 -7,210,418 -1,712,111 -2,682,256 -2,669,936 -2,160,253 -1,902,886 -1,907,280 -2,399,942 -2,000,000 -2,200,000 -2,900,000 -2,600,000 1,000,000 

We provide you with 20 years income statements for Inovio Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Inovio Pharmaceuticals stock. Explore the full financial landscape of Inovio Pharmaceuticals stock with our expertly curated income statements.

The information provided in this report about Inovio Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.